Thermodynamics of standing and lying behavior in lactating dairy cows in freestall and parlor holding pens during conditions of heat stress.

Heat load is a challenge for high-producing dairy cows, with adverse consequences on production, reproduction, and welfare. The objectives of this observational study in 2 commercial dairy herds were to determine the effects of environmental heat stress on standing and lying behavior, to monitor the changes in core body temperature (CBT) of cows during lying and standing bouts, and to compare changes in CBT during standing bouts in freestall pens versus standing in holding pens. High-producing cows were selected for data collection over a period of 6 d of increasing heat stress during a heat wave to which they were not acclimated. A total of 20 cows were fitted with leg accelerometers that recorded lying behavior and with vaginal temperature loggers that recorded CBT. These data were recorded at 30-s intervals. Time in the parlor holding pen was calculated from automated parlor software that recorded milking unit attachment and removal times. Mean daily temperature-humidity index in the pens increased from 68.5 to 79.0 during the 6-d trial, whereas mean daily lying time decreased from 9.5 to 6.2 h/d. The mean number of lying bouts per day remained similar at 11.1 to 12.2, but duration of lying bouts decreased from a high of 49.7 min on the coolest day to 32.8 min on the hottest day. During lying bouts, CBT increased at a mean rate of 0.50°C/h. In contrast, CBT changed at a mean rate of -0.25°C/h when standing in the freestall pens and only -0.09°C/h when standing in the milking-center holding pens. Explanatory models for the CBT at which cows ended either standing or lying bouts were derived from 6 selected lying bouts and 3 selected standing bouts for each cow on each day. The CBT at which a cow ended a lying bout was positively related to CBT and temperature-humidity index at the start of the bout, bout duration, and rate of CBT change during the bout. The CBT at which a cow ended a standing bout was negatively related to bout duration and positively related to start CBT, start temperature-humidity index, and rate of CBT change. Insights into the thermodynamics of standing and lying behavior in dairy cows during periods of heat stress provided by this study may contribute to the development of more effective strategies to mitigate heat load in dairy cattle.

Technical note: Validation of the BHBCheck blood ß-hydroxybutyrate meter as a diagnostic tool for hyperketonemia in dairy cows.

Accurate cow-side blood ß-hydroxybutyrate (BHB) detection meters are valuable tools for rapid diagnosis of hyperketonemia. The main objective of this study was to compare the blood BHB measured in whole blood by the BHBCheck meter (PortaCheck, Moorestown, NJ) to a previously validated meter, Precision Xtra meter (Abbott Laboratories, Abbott Park, IL) and a colorimetric laboratory assay. Samples (n = 426) were collected from postpartum primiparous and multiparous Holstein cows (n = 79 cows) enrolled in 1 of 2 experiments (Exp) with different sampling schedules (Exp 1: n = 39 cows, 58 samples; Exp 2: n = 40 cows, 368 samples). In both Exp, whole-blood samples were collected from the coccygeal vessels after morning milking, before morning feeding. Blood samples were used immediately for BHB quantification via the BHBCheck meter and the Precision Xtra meter. Blood was also collected into evacuated tubes containing no additive (Exp 1) or potassium oxalate/sodium fluoride (Exp 2), which were centrifuged for serum or plasma separation and stored at -20°C for subsequent analysis. Laboratory quantification of BHB concentration was done by the BHB LiquiColor Assay (EKF Diagnostics-Stanbio, Boerne, TX; certified for serum and plasma). Data were analyzed by UNIVARIATE, CORR, FREQ, REG, and LOGISTIC procedures of SAS 9.4 (SAS Institute Inc., Cary, NC). Within this sample set, average parity was 3.3 lactations and DIM was 14 d. The proportion of samples classified as hyperketonemia (BHB ≥1.2 mmol/L) was 25, 28, and 31% as determined by the colorimetric assay, BHBCheck meter, and Precision Xtra meter, respectively. The correlation for BHBCheck meter BHB concentration compared with the colorimetric assay concentrations was r = 0.96, with a sensitivity of 91% and specificity of 93%. Correlation, sensitivity, and specificity of the Precision Xtra meter concentrations were 0.97, 98%, and 92%, respectively. Bland-Altman plots demonstrated minimal bias for both meters. Area under the receiver operator characteristic curve suggests adequate diagnostic accuracy of both meters. Overall, accuracy, sensitivity, and specificity of the BHBCheck meter was similar to the Precision Xtra meter and laboratory assay, indicating the BHBCheck meter is appropriate for use as a cow-side diagnostic test for hyperketonemia in dairy cows.

Predicting hyperketonemia by logistic and linear regression using test-day milk and performance variables in early-lactation Holstein and Jersey cows.

Although cowside testing strategies for diagnosing hyperketonemia (HYK) are available, many are labor intensive and costly, and some lack sufficient accuracy. Predicting milk ketone bodies by Fourier transform infrared spectrometry during routine milk sampling may offer a more practical monitoring strategy. The objectives of this study were to (1) develop linear and logistic regression models using all available test-day milk and performance variables for predicting HYK and (2) compare prediction methods (Fourier transform infrared milk ketone bodies, linear regression models, and logistic regression models) to determine which is the most predictive of HYK. Given the data available, a secondary objective was to evaluate differences in test-day milk and performance variables (continuous measurements) between Holsteins and Jerseys and between cows with or without HYK within breed. Blood samples were collected on the same day as milk sampling from 658 Holstein and 468 Jersey cows between 5 and 20 d in milk (DIM). Diagnosis of HYK was at a serum ß-hydroxybutyrate (BHB) concentration ≥1.2 mmol/L. Concentrations of milk BHB and acetone were predicted by Fourier transform infrared spectrometry (Foss Analytical, Hillerød, Denmark). Thresholds of milk BHB and acetone were tested for diagnostic accuracy, and logistic models were built from continuous variables to predict HYK in primiparous and multiparous cows within breed. Linear models were constructed from continuous variables for primiparous and multiparous cows within breed that were 5 to 11 DIM or 12 to 20 DIM. Milk ketone body thresholds diagnosed HYK with 64.0 to 92.9% accuracy in Holsteins and 59.1 to 86.6% accuracy in Jerseys. Logistic models predicted HYK with 82.6 to 97.3% accuracy. Internally cross-validated multiple linear regression models diagnosed HYK of Holstein cows with 97.8% accuracy for primiparous and 83.3% accuracy for multiparous cows. Accuracy of Jersey models was 81.3% in primiparous and 83.4% in multiparous cows. These results suggest that predicting serum BHB from continuous test-day milk and performance variables could serve as a valuable diagnostic tool for monitoring HYK in Holstein and Jersey herds.

A stochastic estimate of the economic impact of oral calcium supplementation in postparturient dairy cows.

The objective was to develop stochastic models to estimate the economic impact in the first 30 d in milk of oral calcium supplementation to multiparous postparturient dairy cows using 4 different strategies: (1) supplementation of cows with a high previous lactation mature-equivalent milk yield, (2) supplementation of lame cows, (3) supplementation of both cows that have a high previous lactation mature-equivalent milk yield and cows that are lame, and (4) supplementation of all cows. Data from current literature were used to model input variables associated with the costs and risks related to milk production, postparturient disease, and culling. The mean net herd impact per 1,000 calvings for each of the 4 supplementation strategies was $4,425, $5,812, $8,313, and $3,065, respectively. Postpartum supplementation of multiparous lame cows had the highest return on investment at 6.5 to 1, followed by supplementation of multiparous high milk yield and lame cows, multiparous high milk yield cows only, and supplementation of all multiparous postpartum cows with returns of 1.8 to 1, 1.1 to 1, and 0.3 to 1, respectively. A herd's average milk yield at first test had the highest influence on the net impact of oral calcium supplementation to all multiparous cows and accounted for 30% of the variation, followed by the decrease in risk of health events in lame cows given oral calcium at 22%, a herd's prevalence of lameness at calving at 13%, and the price of milk at 10%. Each of the remaining stochastic variables contributed to less than 5% of the variation in net herd financial impact of oral calcium administration. Whereas supplementation of all postpartum multiparous cows returned a positive net herd impact approximately 80% of the time, if a herd was willing to devote time to mature-equivalent milk yield calculations and locomotion scoring, supplementation of this subpopulation of postpartum cows with oral calcium was estimated to have a positive economic impact in all iterations. Depending on the supplementation strategy chosen and baseline milk yield and immediate postpartum lameness prevalence in a herd, a herd with 1,000 calvings per year can expect to see an average net impact ranging from approximately $3,000 to $8,000 after postpartum supplementation of oral calcium in multiparous animals.

Risk factors for postpartum problems in dairy cows: explanatory and predictive modeling.

The postpartum period is associated with a high incidence of most dairy cattle diseases and a high risk of removal from the herd. Postpartum diseases often share risk factors, and these factors may trigger a cascade of other diseases. The objective of this cohort study was to derive explanatory and predictive models for treatment or removal from the herd within the first 30 d in milk (TXR30). The TXR30 outcome was specifically defined as ≥1 treatment for ≥1 occurrence of milk fever, retained placenta, metritis, ketosis, displaced abomasum, lameness, or pneumonia; removal from the herd (sold or died); or both treatment and later herd removal. The study population consisted of 765 multiparous and 544 primiparous cows (predominantly Holstein) from 4 large commercial freestall-housed dairy herds. Treatment or removal from the herd was recorded as a binary outcome for each cow. Potential explanatory and predictive variables were limited to routine cow data that could be collected either before or within 24 h of calving. Models for multiparous and primiparous cows were developed separately because previous lactation variables are available only for multiparous cows. Adjusted odds ratios for TXR30 in the explanatory model for the multiparous cohort were 2.1 for lactation 3 compared with lactation 2, and 2.3 for lactation 4 or greater compared with lactation 2; 2.3 for locomotion score 3 or 4 compared with score 1; 3.3 for an abnormality at calving compared with no calving abnormality; 1.8 for each 1-standard deviation increase in previous lactation length; and 0.4 for each 5,000-kg increment in previous lactation milk yield in cows with longer previous lactation length. The final predictive model for TXR30 in multiparous cows included predictors similar but not identical to those included in the explanatory model. The area under the curve for the receiver operating characteristic curve from the final predictive model for the multiparous cohort was 0.70, with 60% sensitivity. For the primiparous cohort, calving abnormality increased the odds of TXR30 and was the only variable included in both the explanatory and predictive models. The area under the curve for the receiver operating characteristic curve from the final predictive model for the primiparous cohort was 0.66, with 35% sensitivity. This study identified key risk factors for TXR30 and developed equations for the prediction of TXR30. This information can help dairy producers better understand causes of postpartum problems.

Dry period and parturient predictors of early lactation hyperketonemia in dairy cattle.

The purpose was to determine important dry and calving period predictors of (1) a cow developing hyperketonemia at any time between 3 and 16 d in milk (DIM) and (2) a cow having hyperketonemia at her first ß-hydroxybutyrate (BHBA) test after calving (between 3 and 5 DIM). Cows from 4 freestall dairy herds [2 in New York (NY) and 2 in Wisconsin] were enrolled at 266 d carried calf. Precalving data included body condition score, locomotion score, and blood nonesterified fatty acids (NEFA) concentration; calving-associated data included previous days carried calf, calving ease, calf sex, twins, stillbirth, and parity. Cows were each tested 6 times for hyperketonemia from 3 to 16 DIM on Mondays, Wednesdays, and Fridays using the Precision Xtra meter (Abbott Laboratories, Abbott Park, IL). Hyperketonemia was defined as a blood BHBA concentration of ≥1.2 mmol/L. Multivariable fixed-effects Poisson regression models were developed to predict the probability of a cow developing hyperketonemia between either 3 and 16 DIM or at her first BHBA test. As only the NY herds had precalving NEFA data, each prediction model was developed twice: once with data from all 4 herds (n=1,672) and once with data from only the NY herds (n=544). For the models with data from all 4 herds, increased body condition score group and an interaction between advanced parity and herd were important predictors of hyperketonemia development at any time from 3 to 16 DIM; calf sex (male), herd, and an advanced parity by increased body condition score group interaction were important predictors of hyperketonemia development between 3 and 5 DIM. The 4-herd models had a 64 and 78% predictive concordance for hyperketonemia between 3 and 16 DIM and at first BHBA test, respectively. For the models with data from the NY herds only, increased NEFA, calf sex (male), advanced parity, and herd were found to be important predictors of hyperketonemia development at any time from 3 to 16 DIM; increased NEFA, calf sex (male), decreased calving ease, stillbirth, and advanced parity were important predictors of having hyperketonemia at first BHBA test. The NY models had a 69 and 87% predictive concordance, respectively. These results may help identify at-risk animals and improve dry-cow management strategies before hyperketonemia develops.

Effect of oral calcium bolus supplementation on early-lactation health and milk yield in commercial dairy herds.

The objective of this study was to evaluate the effect of supplementation with oral Ca boluses after calving on early-lactation health and milk yield. Cows in their second lactation or greater (n=927) from 2 large dairies in Wisconsin were enrolled during the summer of 2010. Both herds were fed supplemental anions during the prefresh period and less than 1% of fresh cows were treated for clinical milk fever. Cows were scored before calving for lameness and body condition, and then randomly assigned to either a control group or an oral Ca bolus-supplemented group. Control cows received no oral Ca boluses around calving. Cows in the oral Ca bolus group received 2 oral Ca boluses (Bovikalc, Boehringer Ingelheim, St. Joseph, MO), one bolus 0 to 2h after calving and the second 8 to 35 h after calving. The oral Ca bolus administration schedule allowed fresh cows to be restrained in headlocks only once daily. Whole-blood samples were collected immediately before the second oral Ca bolus was given and were analyzed for ionized Ca (Ca(2+)) concentration. Early-lactation health events were recorded and summed for each cow. Only 6 cases (0.6% of calvings) of clinical milk fever occurred during the trial, and only 14% of cows tested were hypocalcemic (Ca(2+) less than 1.0 mmol/L) at 8 to 35 h after calving. Mean Ca(2+) concentrations were not different between the control and oral Ca bolus-supplemented groups. Blood samples from the cows given oral Ca boluses were collected an average of 20.6 h after administration of the first bolus. Subpopulations of cows with significant responses to oral Ca bolus supplementation were identified based on significant interactions between oral Ca bolus supplementation and covariates in mixed multiple regression models. Lame cows supplemented with oral Ca boluses averaged 0.34 fewer health events in the first 30 d in milk compared with lame cows that were not supplemented with oral Ca boluses. Cows with a higher previous lactation mature-equivalent milk production (greater than 105% of herd rank) and supplemented with oral Ca boluses produced 2.9 kg more milk at their first test after calving compared with cows with higher previous lactation milk yields that were not supplemented. Results of this study indicate that lame cows and higher producing cows responded favorably to supplementation with oral Ca boluses. Supplementing targeted subpopulations of cows with oral Ca boluses was beneficial even for dairies with a very low incidence of hypocalcemia.

Epidemiology of subclinical ketosis in early lactation dairy cattle.

The purpose of this study was to describe the epidemiology of subclinical ketosis (SCK) in dairy cows in early lactation and determine the association of (1) days in milk (DIM) at onset of SCK, and (2) blood ß-hydroxybutyrate (BHBA) concentration at onset of SCK with development of displaced abomasum (DA) and removal from herd in the first 30 DIM, conception to first service, days to conception within 150 DIM, and early lactation milk yield. Cows from 4 freestall dairy herds (2 in New York and 2 in Wisconsin) were each tested 6 times for SCK from 3 to 16 DIM using the Precision Xtra meter (Abbott Laboratories, Abbott Park, IL). Subclinical ketosis was defined as a BHBA concentration of 1.2 to 2.9 mmol/L. Mixed-effects multivariable Poisson regression was used to assess DA, removal from herd, and conception to first service. Semiparametric proportional hazards models were used to evaluate days to conception, and repeated-measures ANOVA was used to evaluate milk yield in the first 30 DIM. A total of 741 of 1,717 (43.2%) eligible cows had a least one BHBA test of 1.2 to 2.9 mmol/L. Peak incidence of SCK occurred at 5 DIM, when 22.3% of cows had their first SCK-positive test. Peak prevalence of SCK occurred at 5 DIM, when 28.9% of cows had a SCK-positive test. Median time from first positive SCK test until BHBA test <1.2 mmol/L was 5d. Cows first testing SCK positive from 3 to 5 DIM were 6.1 times more likely [95% confidence interval (CI) = 2.3 to 16.0] to develop a DA than cows first testing SCK positive at 6 DIM or later. Cows first testing SCK positive from 3 to 7 DIM were 4.5 times more likely (95% CI = 1.7 to 11.7) to be removed from the herd, were 0.7 times as likely (95% CI = 0.6 to 0.8) to conceive to first service, and produced 2.2 kg less milk per day for the first 30 DIM than cows first testing positive at 8 DIM or later. Each 0.1 mmol/L increase in BHBA at first SCK-positive test increased the risk of developing a DA by a factor of 1.1 (95% CI = 1.0 to 1.2), increased the risk of removal from herd by a factor of 1.4 (95% CI = 1.1 to 1.8), and was associated with a decrease in milk production by 0.5 kg/d for the first 30 DIM. These results show that time of onset and BHBA concentration of first SCK-positive test are important indicators of individual cow performance.

A field trial on the effect of propylene glycol on displaced abomasum, removal from herd, and reproduction in fresh cows diagnosed with subclinical ketosis.

The purpose was to determine the effect of oral propylene glycol (PG) administration in fresh cows diagnosed with subclinical ketosis (SCK). Measured outcomes were development of displaced abomasum (DA) and removal from herd in the first 30 d in milk (DIM), conception to first service, and time to conception within 150 DIM. Cows from 4 freestall dairy herds (2 in New York and 2 in Wisconsin) were each tested 6 times for SCK from 3 to 16 DIM on Mondays, Wednesdays, and Fridays using the Precision Xtra meter (Abbott Laboratories, Abbott Park, IL). Subclinical ketosis was defined as a blood ß-hydroxybutyrate concentration of 1.2 to 2.9 mmol/L. Cows with SCK were randomized to treatment group (oral PG) or untreated control group (no PG); treatment cows were orally drenched with 300 mL of PG once daily from the day they tested 1.2 to 2.9 mmol/L until the day they tested <1.2 mmol/L. Mixed effects multivariable Poisson regression was used to assess the effect of PG on DA, removal from herd, and conception to first service; a semiparametric proportional hazards model was used to evaluate the days-to-conception outcome. A total of 741 of 1,717 (43.2%) eligible enrolled cows had at least 1 ß-hydroxybutyrate test of 1.2 to 2.9 mmol/L. Of these, 372 were assigned to the PG treatment group and 369 to the control group. Thirty-nine cows (5.3%) developed a DA after testing positive for SCK and 30 cows (4.0%) died or were sold within the first 30 DIM. Based on risk ratios, control cows were 1.6 times more likely [95% confidence interval (CI)=1.3 to 2.0] to develop a DA and 2.1 times more likely (95% CI=1.2 to 3.6) to die or be sold than cows treated with PG. In addition, PG-treated cows were 1.3 times more likely (risk ratio 95% CI=1.1 to 1.5) to conceive at first insemination than control cows in 3 of the herds. No difference was observed in days to conception within 150 DIM between treatment groups (hazard ratio for PG cows=1.1, 95% CI=0.8 to 1.4), with a median time to conception of 100 d (95% CI=93 to 111) and 104 d (95% CI=95 to 114) for PG-treated and control cows, respectively. These results show that intensive detection of SCK, followed by treatment of positive cows with oral PG decreased the risk of developing a DA or leaving the herd within the first 30 DIM and increased the risk of conception to first service.

A field trial on the effect of propylene glycol on milk yield and resolution of ketosis in fresh cows diagnosed with subclinical ketosis.

The purpose of this study was to determine the effect of oral propylene glycol (PG) administration on ketosis resolution and milk yield in cows diagnosed with subclinical ketosis (SCK). Cows from 4 freestall dairy herds (2 in New York and 2 in Wisconsin) were each tested 6 times for SCK from 3 to 16 d in milk on Mondays, Wednesdays, and Fridays. Subclinical ketosis was defined as a ß-hydroxybutyrate (BHBA) concentration of 1.2 to 2.9 mmol/L, [corrected] and clinical ketosis was defined as ≥ 3.0 mmol/L. [corrected]. Cows with SCK were randomized to the treatment group (oral PG) or control group (no PG); treatment cows were drenched with 300 mL of PG once daily from the day they tested 1.2 to 2.9 mmol/L [corrected] until the day they tested <1.2 mmol/L. [corrected]. Outcomes evaluated for all farms included time from SCK until BHBA test <1.2 mmol/L [corrected] or until BHBA test ≥ 3.0 mmol/L. [corrected]. Individual milk weights for the first 30 d of lactation were evaluated for the 3 farms monitoring daily milk. Semiparametric proportional hazards models were used to evaluate time to event outcomes; repeated-measures ANOVA was used to assess milk weights. A total of 741 of 1,717 (43.2%) eligible enrolled cows had at least one BHBA test of 1.2 to 2.9 mmol/L. [corrected]. Of these, 372 were assigned to the treatment group and 369 to the control group. Based on hazard ratios, PG-treated cows were 1.50 times more likely (95% confidence interval=1.26 to 1.79) to resolve their SCK and 0.54 times less likely (95% confidence interval=0.34 to 0.86) to develop clinical ketosis than control cows. Across the 3 herds measuring individual milk weights, treated cows produced 0.23 kg more milk per milking in the first 30 d of lactation than control cows, for a total difference of 0.69 kg/cow per day. After identification of a treatment by herd interaction, stratification by herd showed that treated cows produced more milk per milking on farm A (0.44 kg) and farm B (0.53 kg) in the first 30 d of lactation than control cows, for a total difference of 1.34 and 1.59 kg/d, respectively; milk production did not differ (0.02 kg per milking) between the 2 groups on farm D. These results show the positive effects of oral PG administration in fresh cows with SCK by helping to resolve SCK and preventing clinical ketosis. In addition, oral PG improves milk yield during early lactation in cows diagnosed with SCK.

Effect of a low-moisture buffer block on ruminal pH in lactating dairy cattle induced with subacute ruminal acidosis.

The objective of this study was to evaluate the effect of a low-moisture buffer block on ruminal pH and milk production in cows induced with subacute ruminal acidosis (SARA). Sixteen ruminally cannulated cows were randomly assigned to treatment (access to buffer blocks) or control (no buffer blocks). Ruminal pH was recorded each minute; dry matter intake (DMI), milk yield, and milk composition were measured daily. The experiment lasted 12 d and consisted of a 3-d pre-SARA period (without access to buffer blocks; d 1 to 3), after which 8 cows were given access to buffer blocks and 8 cows continued without access to buffer blocks. The next 4 d (d 4 to 7) were for evaluating the response to buffer blocks. On d 8, cows were restricted to 50% of previous DMI, and on d 9 SARA was induced (addition of 4 kg of wheat/barley pellet to pre-SARA total mixed ration (TMR). Cows were then monitored for a 3-d recovery period (d 10 to 12). The SARA challenge was successful in decreasing mean ruminal pH and time and area below pH 5.6. Intake of buffer blocks averaged 0.33 kg of DM/cow per day and was greatest on d 4 and d 8. Total DMI (TMR plus buffer block) and yields of milk and milk components were not affected by treatment. Although there was no overall effect of treatment on any of the ruminal pH variables measured, there were significant treatment by period interactions for several ruminal pH variables. Cows on the control treatment tended to experience a greater decrease in mean ruminal pH when induced with SARA than cows with access to buffer blocks (-0.55 vs. -0.20 pH units). Cows on the control treatment also experienced a greater increase in time (9.7 vs. 4.1 h/d) and area (249 vs. 83 min x pH units/d) below pH 5.6 compared with cows with access to buffer blocks. Ruminal volatile fatty acids, lactate, ethanol, and succinate concentrations during the SARA challenge did not differ between treatments. Eating behavior was not affected by treatment. Size of the first meal of the day was greater on the SARA challenge day than during the pre-SARA period (11.0 vs. 5.7 kg, as fed). Giving cows access to a buffer-containing molasses block may reduce the duration and the severity of a 1-d SARA challenge.

Direct-fed microbial supplementation and health and performance of pre- and postpartum dairy cattle: a field trial.

A double-blind field trial was conducted on a commercial dairy to study the effects of feeding a direct-fed microbial (DFM) product consisting of 2 strains of Enterococcus faecium plus Saccharomyces cerevisiae yeast on prepartum and postpartum performance of Holstein cows. Treatments consisted of the normal pre- and post-fresh TMR supplemented with the DFM (2 g/cow per d) or a placebo. Treatments started approximately 10 d prepartum and continued until about 23 d in milk (DIM). A total of 366 Holstein cows were enrolled in 1 of 2 placebo groups or 2 DFM-supplemented groups. Groups were enrolled consecutively, starting with the placebo treatment. Sample size was limited to 4 groups because the cooperating dairy prematurely terminated the study due to increased health problems in one of the groups. Blood samples were taken during the prefresh period between 2 and 10 d prior to calving and at weekly intervals from 3 to 23 DIM. Blood concentrations of nonesterified fatty acids before calving and beta-hydroxy-butyrate after calving were not affected by treatment. Supplementation with the DFM product increased milk fat percentage for the first lactation cows and increased milk protein percentage for the second and greater lactation cows during the first 85 DIM. Second-lactation cows fed the DFM product received fewer antibiotic treatments before 85 DIM than cows receiving the placebo. This validated the dairy producer's concern that cows consuming one of the diets (revealed to be the placebo diet after the study was completed) were experiencing more health problems. Most measures of milk yield were numerically increased by supplementation with the DFM product. However, differences in milk yield were not significant. Key covariates for main study outcomes included milk yield in the previous (first) lactation, body condition score prior to calving, days spent in the maternity pen, and stocking density of the pre-fresh pen.

Decreased insulin response in dairy cows following a four-day fast to induce hepatic lipidosis.

Negative energy balance has been implicated in the development of fatty liver, insulin resistance, and impaired health in dairy cows. A 4-d fasting model previously was reported to increase liver triglycerides more than 2.5-fold. The purpose of the present study was to evaluate insulin response in this fasting model. Nonlactating, nonpregnant Holstein cows were fasted for 4 d (6 cows) or fed continuously as control cows (4 cows). Samples were collected 5 d before fasting, during fasting, and immediately after the 4-d fast, 8 d after the fast, and 16 d after the fast. Fasted cows had greater liver triglyceride content (49.4 vs. 16.2 mg/g, wet-weight basis) at the end of the fasting period compared with control cows. Fasted cows also had increased plasma nonesterified fatty acid (NEFA) concentrations (1.24 vs. 0.21 mmol/L) and increased plasma beta-hydroxybutyrate (BHBA) concentrations at the end of the fasting period. Liver triglyceride, plasma NEFA, and plasma BHBA in fasted cows returned to prefasting concentrations by the end of the experiment. Plasma glucose concentrations were not affected by fasting. Plasma insulin concentrations were decreased (6.3 vs. 14.1 microU/mL) and insulin-stimulated blood glucose reduction was decreased (24.9 vs. 48.6%) in the fasted cows compared with control cows at the end of the fast, indicating reduced insulin response. Insulin response was negatively correlated with plasma NEFA and liver triglycerides. Decreased insulin response may be an important complication of negative energy balance and hepatic lipidosis.

Impact of lowering dietary cation-anion difference in nonlactating dairy cows: a meta-analysis.

A meta-analysis of previous studies was performed to clarify the response of prepartum dairy cows to lowering dietary cation-anion difference (DCAD) and to compare different equations that have been proposed to calculate DCAD. Twenty-two published studies containing 75 treatment groups met criteria for inclusion in the meta-analysis. Five different equations used to calculate DCAD were compared for their association with clinical milk fever and urinary pH. The DCAD equation (Na + K) - (Cl + 0.6 S) was the most highly associated with clinical milk fever (R(2) = 0.44) and urinary pH (R(2) = 0.85). Lowering DCAD reduced clinical milk fever but also reduced DM intake. Lowered DCAD was associated with reduced urinary pH, blood bicarbonate, and blood CO(2), suggesting a metabolic acidosis with respiratory compensation. Blood pH was very slightly lowered by lowered DCAD. Lowering DCAD increased ionized Ca in blood before and at calving. The model predicted that lowering DCAD from +300 to 0 mEq/kg reduced risk for clinical milk fever from 16.4 to 3.2%, reduced urinary pH from about 8.1 to 7.0, and reduced DM intake by 11.3%.

Inducing subacute ruminal acidosis in lactating dairy cows.

Data from experiments in which subacute ruminal acidosis (SARA) was induced in lactating dairy cows (days in milk = 154 +/- 118) were evaluated to investigate the effectiveness of the induction protocol and its effect on production outcomes. For 13 cows in 3 trials, ruminal pH was measured continuously and recorded each minute; dry matter intake and milk yield were recorded daily. Milk composition data were obtained from 9 cows in 2 of these trials. The SARA induction protocol included 4 separate periods: 4 d of baseline [normal total mixed ration (TMR)], 1 d of 50% restricted feeding, 1 or 2 d of challenge feeding [addition of 3.5 or 4.6 kg of wheat-barley pellet (dry matter basis) to normal TMR], and 2 d of recovery measurements when feeding normal TMR. The SARA induction protocol lowered mean ruminal pH from 6.31 during the baseline period to 5.85 during the challenge period; pH remained below baseline level during the recovery period (6.16). Mean ruminal pH was highest (6.59) during the day of restricted feeding. Nadir ruminal pH decreased from baseline to challenge period (5.76 vs. 5.13). Hours below pH 5.6 increased from 1.10 to 8.26/d from baseline to challenge period and area below 5.6 (pH x min/d) increased from 15.0 to 190.3. Dry matter intake was not affected by SARA induction. Milk yield dropped from 35.2 kg/d during baseline to 31.7 k/d during the challenge period and did not return to baseline level during the recovery period (31.3 kg/d). No depression in milk fat percentage was observed when SARA was induced. Yield of fat was highest during the restricted feeding period (1.47 kg/d) and was lower during the recovery period than during the baseline period (1.12 vs. 1.31 kg/d). The protocol successfully induced SARA (low ruminal pH without signs of acute ruminal acidosis) on the challenge day. Milk yield was substantially reduced and did not recover within 2 d after the challenge.

Effect of calcium chloride gel treatment in dairy cows on incidence of periparturient diseases.

OBJECTIVE: To determine effect of prophylactic treatment of dairy cattle with a calcium chloride gel on serum calcium concentration in the immediate postpartum period and incidence of parturient paresis, retained fetal membranes, and displacement of the abomasum. DESIGN: Randomized controlled trial. ANIMALS: 204 Holstein cows. PROCEDURE: Cows were paired according to parity, whether they had previously had parturient paresis, and expected calving date. Cows in the treatment group received doses of calcium chloride gel 12 hours before expected calving, at calving, and 12 and 24 hours after calving. Cows in the control group did not receive calcium chloride gel. RESULTS: Compared with concentration in the control cows, mean serum calcium concentration in cows treated with calcium chloride gel was significantly increased on postcalving days 1 and 2. The increase was significant only in cows that were third parity or greater. Calcium chloride gel treatment also resulted in significantly reduced incidence of parturient paresis, parturient hypocalcemia, and displaced abomasum. The incidence of parturient paresis was lower in cows that received the precalving dose of calcium chloride gel (0/39) than in cows that did not receive the precalving dose (5/63). CLINICAL IMPLICATIONS: Results suggest that periparturient prophylactic treatment of dairy cattle with an oral calcium chloride gel may be beneficial and that treatment would be most effective for cows of third parity or greater. Administration of a precalving dose of calcium chloride gel is necessary to reduce the incidence of parturient paresis, but postcalving treatment alone has other beneficial effects.

Parturient paresis and hypocalcemia in ruminant livestock.

Parturient paresis (hypocalcemia) is most likely to affect dairy cattle around the time of parturition. It causes progressive neuromuscular dysfunction and flaccid paralysis. Older dairy cows, cows with a history of parturient paresis during a previous lactation, high-producing cows, and cows from the Jersey and Guernsey breeds are at highest risk for developing parturient paresis. Nonparturient hypocalcemia may also occur and is related to events other than parturition, such as severe stress, that temporarily overwhelm the mechanisms of calcium homeostasis. Beef cattle, sheep, and goats are affected less frequently by hypocalcemia than are dairy cows. Because these species are not as stressed for milk production as dairy cattle, nonparturient hypocalcemia makes up a higher proportion of cases in nondairy ruminants. Clinical signs of hypocalcemia in beef cattle, sheep, and goats tend toward hyperesthesia and tetany rather than the classic flaccid paralysis that occurs in dairy cattle with parturient hypocalcemia. Prompt and effective treatment of hypocalcemia helps to reduce the incidence of secondary complications, such as muscle damage or mastitis. The standard treatment regimen of 500 ml of 23 per cent calcium gluconate, administered intravenously, will elicit a favorable response in approximately 75 per cent of recumbent cows within 2 hours of treatment. Relapses following successful initial therapy are common and may be prevented in part by supplementation of intravenous treatment with an additional 500 ml of 23 per cent calcium gluconate administered subcutaneously. Proper nursing care following treatment speeds recovery and reduces the incidence of secondary complications owing to hypocalcemia.

Protein-energy malnutrition in ruminants.

Protein-energy malnutrition occurs when feed is provided to ruminant livestock in insufficient quantity, quality, or both. The clinical syndrome that results from protein-energy malnutrition is not difficult to recognize, but it may be difficult to convince owners of the diagnosis. Development of clinical signs, such as recumbency and hypothermia, may occur rapidly owing to the sudden failure of homeostatic mechanisms that maintain the supply of cellular fuels. The ruminant is unique in its response to malnutrition because ruminal microorganisms become malnourished just as their host does. Ruminal maldigestion hastens the onset of clinical signs and makes recovery very difficult and prolonged. Clinical signs of PEM are similar in adult beef cattle, dairy cattle, sheep, and goats; however, the typical history of affected animals varies for each of these species. Neonatal ruminants may also be severely affected with PEM if they do not receive sufficient colostrum and milk. Definitive diagnosis of primary PEM requires necropsy of an affected animal. Diagnosis of PEM in an individual animal usually indicates a herd or flock problem that requires immediate attention. If the affected individual is already recumbent, then treatment will likely be difficult and unsuccessful. Changes in management of the herd or flock that involve ensuring adequate feed intake, minimizing cold and social stress, and meeting the animal's specific nutritional requirements will prevent PEM and maximize production.

Management of dry cows for the prevention of milk fever and other mineral disorders.

Mineral disorders in dairy cattle typically occur soon after calving and are often specifically related to nutritional management during the late dry period. The incidence of hypocalcemia, hypophosphatemia, and hypomagnesemia can be minimized by proper diet formulation and good overall nutritional management in the dry period. The addition of anions to the diet during the late dry period may be of particular benefit for preventing hypocalcemia; however, supplementation with anions will reduce dry matter intake if feeding management is not excellent.

An economic analysis of hyperketonemia testing and propylene glycol treatment strategies in early lactation dairy cattle.

The purpose was to develop stochastic economic models which address variation in disease risks and costs in order to evaluate different simulated on-farm testing and propylene glycol (PG) treatment strategies based on herd hyperketonemia (HYK) incidence during the first 30 DIM. Data used in model development concerning the difference in health and production consequences between HYK and non-ketotic cows were based on results from 10 studies representing over 13,000 cows from 833 dairy farms in North America, Canada, and Europe. Inputs for PG associated variables were based on a large field trial using cows from 4 free-stall dairy herds (2 in New York and 2 in Wisconsin). Four simulated on-farm testing and treatment strategies were analyzed at herd HYK incidences ranging from 5% to 80% and included: 1) treating all cows with 5d of PG starting at 5 DIM, 2) testing all cows for HYK 1 day per week (e.g. Mondays) from 3 to 16 DIM and treating all positive cows with 5d of oral PG, 3) testing all cows for HYK 2 days per week (e.g. Mondays and Thursdays) from 3 to 9 DIM and treating all positive cows with 5d of oral PG, and 4) testing all cows for HYK 3 days per week (e.g. Mondays, Wednesdays, and Fridays) from 3 to 16 DIM and treating all positive cows with 5d of oral PG. Cost-benefit analysis included the costs associated with labor to test cows, ß-hydroxybutyrate test strips, labor to treat cows, PG, and the associated gain in milk production, decrease in DA and early removal risks of PG treated HYK positive cows compared to non-treated HYK positive cows. Stochastic models were developed to account for variability in the distribution of input variables. Per 100 fresh cows in a herd with an HYK incidence of 40%, the mean economic benefits of the 4 different strategies were $1088, $744, $1166, and $760, respectively. Testing cows 2 days per week from 3 to 9 DIM was the most cost-effective strategy for herds with HYK incidences between 15% and 50%; above 50%, treating all fresh cows with 5d of PG was the most cost-effective strategy. These results show that for herds similar to those used in model, when herd HYK incidences rise above 25%, almost any HYK testing and treatment protocol will be economically beneficial for the farm.